fda statement on bpc-157 Briefing Document Pharmacy Compounding Advisory Committee (PCAC) Meeting July 23 fda bpc-157 not approved human
Description
Per-component dose ranges in published preclinical research differ across the three compounds, with each component examined under distinct dosing protocols by independent research groups
Should hCG be injected subcutaneously or intramuscularly

Determine Optimal Dosing and Administration: Establish standardized and evidence-based dosing protocols, frequencies, and routes of administration for various indications

doi: 10.1016/0005-2728(94)90180-5

Baseline b12 level tests at 550 pg per milliliter
